Your allergy
What is allergy
House dust mite allergy
Pollen allergy
Living with allergy
Socio-economic impact
What is allergic asthma
How is allergy diagnosed
Treating allergy
Our solutions
Consumer healthcare
Diagnostics
Allergy vaccines
Production and quality
Emergency medicine
Our science
Scientific focus
Science & technology
Pipeline
Digital innovation
Collaboration & partnerships
Healthcare Professionals
Allergy immunotherapy
Our data
Clinical trials
Real-world evidence
Clinical data sharing
Henning Løwenstein Research Award
Symposium on Specific Allergy
Medical events
Our company
Newsroom
Stories
Strategy
Privacy
Global presence
Organisation
History
Owners
Sustainability
Environmental
Social
Governance
Investors
Overview
Financial reporting
Risk management
Reporting standards
Auditors
Governance
IR policy
Executive Leadership Team
Board of directors
News & Events
Company releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024
The Share
Dividend history
Analyst coverage
Analyst estimates
Shareholder information
Authorizations
ADR Programme
Contact IR
Annual general meeting
Annual general meeting (DK)
Capital Markets Day 2024
Careers
Working at ALK
Vacant positions
Cultural Beliefs
Select country
Fulltext search
Search
Market Access Manager
Read more
about Market Access Manager
EasyCruit ID
3505205
Department ID
112659
Location
Hamburg, Germany
Vacancy URL
https://alkabello.easycruit.com/vacancy/3505205/112659
Expire Date
Mon, 06/30/2025 - 12:00
Last updated:
20.05.2025
Product Manager – Allergen Immunotherapy (AIT)
Read more
about Product Manager – Allergen Immunotherapy (AIT)
EasyCruit ID
3503923
Department ID
115227
Location
Paris, France
Vacancy URL
https://alkabello.easycruit.com/vacancy/3503923/115227
Expire Date
Mon, 06/30/2025 - 12:00
Last updated:
15.05.2025
ITULATEK® approved for treatment of children and adolescents in Canada
Read more
about ITULATEK® approved for treatment of children and adolescents in Canada
Link
https://www.globenewswire.com/news-release/2025/05/08/3077431/0/en/ITULATEK-app…
Created date
Thu, 05/08/2025 - 12:00
Nasdaq ID
3077431
Last updated:
08.05.2025
Wharehouse Main Operator
Read more
about Wharehouse Main Operator
EasyCruit ID
3500171
Department ID
109023
Location
MADRID
Vacancy URL
https://alkabello.easycruit.com/vacancy/3500171/109023
Expire Date
Fri, 06/06/2025 - 12:00
Last updated:
07.05.2025
Three-month interim report (Q1) 2025 (unaudited)
Read more
about Three-month interim report (Q1) 2025 (unaudited)
Link
https://www.globenewswire.com/news-release/2025/05/06/3074684/0/en/Three-month-…
Created date
Tue, 05/06/2025 - 12:00
Nasdaq ID
3074684
Last updated:
06.05.2025
ALK enters into neffy® co-promotion agreement in the USA
Read more
about ALK enters into neffy® co-promotion agreement in the USA
Link
https://www.globenewswire.com/news-release/2025/05/02/3073224/0/en/ALK-enters-i…
Created date
Fri, 05/02/2025 - 12:00
Nasdaq ID
3073224
Last updated:
02.05.2025
Key Account Manager
Read more
about Key Account Manager
EasyCruit ID
3485759
Department ID
189887
Location
England (East Midlands, South West, North East)
Vacancy URL
https://alkabello.easycruit.com/vacancy/3485759/189887
Expire Date
Mon, 06/30/2025 - 12:00
Last updated:
02.05.2025
Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025
Read more
about Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025
Link
https://www.globenewswire.com/news-release/2025/04/29/3070453/0/en/Invitation-t…
Created date
Tue, 04/29/2025 - 12:00
Nasdaq ID
3070453
Last updated:
29.04.2025
Senior Tracking & Analytics Specialist
Read more
about Senior Tracking & Analytics Specialist
EasyCruit ID
3496193
Department ID
220831
Location
Kraków
Vacancy URL
https://alkabello.easycruit.com/vacancy/3496193/220831
Expire Date
Mon, 06/30/2025 - 12:00
Last updated:
25.04.2025
ITULAZAX® tree pollen tablet approved for treatment of children in Europe
Read more
about ITULAZAX® tree pollen tablet approved for treatment of children in Europe
Link
https://www.globenewswire.com/news-release/2025/04/23/3066532/0/en/ITULAZAX-tre…
Created date
Wed, 04/23/2025 - 12:00
Nasdaq ID
3066532
Last updated:
23.04.2025
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Current page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next ›
Last page
Last »
Subscribe to